PaMeLa, Inc.
PrivateLast Round
Series B
Oct 1, 2021
Est. Valuation
$12.34M
Total Funding Raised
$4.56M
Company Overview
PaMeLa, Inc. operates in Healthcare & Life Sciences and is based in Toyonaka. Its latest recorded funding round was a Series B round in October 2021.
PaMeLa, Inc. is a healthcare technology company that develops EEG-based AI systems to objectively quantify and visualize pain levels for medical diagnosis and pharmaceutical research.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PaMeLa, Inc. Comparables
Compare PaMeLa, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medasense Biometrics | 81% | |
| BioTraceIT | 81% | |
| MedStorm Innovation | 78% |
For institutional investors. Book with your work email.
PaMeLa, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 1, 2021 | ||||
| Strategic | Dec 31, 2019 | ||||
| Series A | Apr 30, 2019 |
For institutional investors. Book with your work email.
PaMeLa, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedVenture Partners | Series A |
| NEC Capital Solutions | Series B |
| OUVC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2021
$4.56M round with Dai-ichi Life Insurance and NEC Capital Solutions.
- Dec 31, 2019
Teikoku Seiyaku Co., Ltd. participated in the strategic round.
For institutional investors. Book with your work email.
PaMeLa, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PaMeLa, Inc.'s valuation, stock price, and market status.
Is PaMeLa, Inc. a public or private company?
PaMeLa, Inc. is a private company.
What is the current stock price of PaMeLa, Inc.?
PaMeLa, Inc. is a private company, so its shares have no public market price. Caplight tracks PaMeLa, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PaMeLa, Inc. worth (valuation)?
PaMeLa, Inc.'s valuation is estimated at $12.3M based on funding round data.
Can I buy PaMeLa, Inc. stock?
PaMeLa, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PaMeLa, Inc.'s last funding round?
PaMeLa, Inc.'s most recent funding round was Series B on October 1, 2021.
Who are the main investors in PaMeLa, Inc.?
Key investors in PaMeLa, Inc. include MedVenture Partners, NEC Capital Solutions, OUVC.
Will PaMeLa, Inc. IPO soon?
No public IPO plans have been announced for PaMeLa, Inc..
How can I track PaMeLa, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PaMeLa, Inc.'s shares on secondary markets.